dienogest has been researched along with Cardiovascular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dinger, J; Do Minh, T; Heinemann, K | 1 |
| Aygun, E; Dansuk, R; Kucukercan, I; Pirimoglu, ZM; Turan, C; Unal, O | 1 |
| Gräser, T; Lüdtke, R; Mueck, AO; Seeger, H; Wallwiener, D | 1 |
| Skouby, SO | 1 |
1 review(s) available for dienogest and Cardiovascular Diseases
| Article | Year |
|---|---|
The rationale for a wider range of progestogens.
Topics: Androstenes; Biological Availability; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estranes; Estrogen Replacement Therapy; Female; Gonanes; Humans; Nandrolone; Osteoporosis, Postmenopausal; Pregnanes; Primary Prevention; Progestins; Treatment Outcome | 2000 |
2 trial(s) available for dienogest and Cardiovascular Diseases
| Article | Year |
|---|---|
The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
Topics: Adult; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Female; Homocysteine; Humans; Middle Aged; Nandrolone; Postmenopause; Treatment Outcome | 2005 |
Effect on biochemical vasoactive markers during postmenopausal hormone replacement therapy: estradiol versus estradiol/dienogest.
Topics: Administration, Oral; Atrial Natriuretic Factor; Biomarkers; Cardiovascular Diseases; Cyclic GMP; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Nandrolone; Peptide Fragments; Postmenopause; Prospective Studies; Serotonin; Vasodilation | 2001 |
1 other study(ies) available for dienogest and Cardiovascular Diseases
| Article | Year |
|---|---|
Impact of estrogen type on cardiovascular safety of combined oral contraceptives.
Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Nandrolone; Patient Reported Outcome Measures; Proportional Hazards Models; Prospective Studies; Surveys and Questionnaires; United States; Venous Thromboembolism; Young Adult | 2016 |